Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Topstories https://ift.tt/3nX8fwP
Subscribe to:
Post Comments (Atom)
McDonald's invests $100 million to recover from E. coli outbreak
McDonald's is investing \$100 million to regain customer trust after an E. coli outbreak linked to onions in its Quarter Pounders sicken...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
No comments:
Post a Comment